Sight Sciences, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $77.4M | $79.9M | $81.1M | $71.3M | $49.0M |
| Gross profit | $66.7M | $68.3M | $69.2M | $59.0M | $40.3M |
| Operating income | -$37.1M | -$50.5M | -$57.3M | -$84.0M | -$51.5M |
| Operating expenses | $103.8M | $118.8M | $126.4M | $142.9M | $91.8M |
| Cost of revenue | $10.7M | $11.6M | $11.9M | $12.4M | $8.6M |
| Cash from operations | -$29.7M | -$22.4M | -$47.2M | -$76.0M | -$52.5M |
| Capital expenditure | $224,000 | $385,000 | $791,000 | $970,000 | $813,000 |
| Free cash flow | -$29.9M | -$22.7M | -$48.0M | -$76.9M | -$53.4M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $115.3M | $142.8M | $166.7M | $213.1M | $280.2M |
| Total liabilities | $51.4M | $55.3M | $46.4M | $53.0M | $48.1M |
| Total debt | $40.3M | $39.4M | $33.9M | $33.3M | $32.7M |
Shares outstanding 54.4M · Free float 67.5%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.